Deniz Granit1*, Turgay Ulas2 and Mehmet Sinan Dal3
1Near East Hospital, School of Medicine, Department of Internal Medicine, Nicosia, Cyprus 2Near East Hospital, School of Medicine, Department of Internal Medicine, Division of Hematology, Nicosia, Cyprus 3Ankara Oncology Hospital, University of Health Science, Department of Internal Medicine, Division of Hematology, Ankara, Turkey
*Corresponding Author: Deniz Granit, Near East Hospital, School of Medicine, Department of Internal Medicine, Nicosia, Cyprus.
Received: March 09, 2023; Published: March 20, 2023
Myelodysplastic syndrome(s) (MDS) are a group of hemopoietic stem-cell disorders characterized by ineffective hematopoiesis and dysplasia. The clinical presentation is not specific in MDS and initial symptoms are generally related to the underlying cytopenias. Thrombotic thrombocytopenic purpura (TTP) is a life threatening condition with thrombocytopenia and hemolytic anemia in which immediate initiation of treatment is critically important. Fragmented erythrocytes (schistocytes) are classically observed in TTP and are rarely a sign for MDS. Herein, we aim to report a 41 year-old woman having thrombotic microangiopathy in admittance and then eventually diagnosed with MDS.
Keywords: Myelodysplastic Syndrome; Thrombotic Microangiopathy; Transplantation
Citation: Deniz Granit., et al. “Myelodysplastic Syndrome Mimicking Thrombotic Thrombocytopenic Purpura Treated with Allogeneic Bone Marrow Transplantation". Acta Scientific Gastrointestinal Disorders 6.4 (2023): 04-07.
Copyright: © 2023 Deniz Granit., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.